Science | Page 16 of 29

Positive Results for First-Generation Artificial Pancreas System

Positive results from the first feasibility study of an advanced first-generation artificial pancreas system were presented at the 72nd Annual American Diabetes Association Meeting in Philadelphia. Findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System...

Cebix Presents C-peptide Replacement Therapy Data

Cebix Incorporated today announced that data from a Phase 1 study demonstrated that Ersatta(TM), the company's long-acting form of C-peptide, was well tolerated with no serious adverse events in patients with type 1 diabetes and exhibited...

DiaPep277 Granted Orphan Drug Designation by FDA

The U.S. FDA has granted Orphan Drug designation for DiaPep277 for the treatment of type 1 diabetes (T1D) patients with residual beta cell function. The designation of Orphan Drug status offers 7 years marketing exclusivity from the time of approval....

Proving the Hygiene Hypothesis?

The hygiene hypothesis sounds plausible, especially in light of studies that have found increasing rates of diseases like type 1 diabetes in developed and developing countries...

Dexcom to Develop a “Smart Transmitter” as Part of JDRF Artificial Pancreas Project

JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wireless “smart transmitter” that would allow a continuous glucose monitor (CGM) system to communicate directly with an artificial pancreas...

Kamada Announces Positive Preliminary Results for New Type 1 Diabetes Therapy

Kamada, announced positive preliminary interim results from a Phase I/II clinical trial of D1-AAT, which includes the Alpha 1 protein, for the treatment of type 1 diabetes. D1-AAT may slow the progression of the type 1 diabetes, and may greatly reduce or eliminate, the need for insulin...

Medtronic: Designing a Closed Loop System

Lane Desborough, Product Strategist at Medtronic, led a discussion of the closed loop system, and what his team faces in designing one...

Researchers Find Possible Trigger in Development of Type 1 Diabetes

JDRF-funded scientists from the Indiana University School of Medicine have found that a specific type of cellular stress takes place in pancreatic beta cells before the onset of type 1 diabetes and this stress response in the beta cell may in fact help ignite the autoimmune attack....

JDRF Research Summit: Toward a Cure and Better Living with Type 1 Diabetes

On Feb. 18 I moderated the JDRF Capitol Chapter’s second annual Research Summit on Type 1 Diabetes...

First US Artificial Pancreas Outpatient Trial Approved by FDA

The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United States, marking a critical development in the effort by JDRF and its allies to bring this innovative and lifesaving diabetes technology to people with type 1 diabetes...